Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-07
2005-06-07
Landsman, Robert (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S247000, C514S269000
Reexamination Certificate
active
06903121
ABSTRACT:
Compounds of Formula 1Formula 1where the symbols have the meaning described in the specification, and particularly the compound of Formula 3Formula 3 (tazarotene)exhibit synergistic anti-proliferative effect with human recombinant interferon in the treatment of solid tumors and leukemia, particularly breast cancer and acute myeloid leukemia.
REFERENCES:
patent: 4810804 (1989-03-01), Chandraratna
patent: 4980369 (1990-12-01), Chandraratna
patent: 5045551 (1991-09-01), Chandraratna
patent: 5089509 (1992-02-01), Chandraratna
patent: 5602130 (1997-02-01), Chandraratna
patent: 6028088 (2000-02-01), Pershadsingh et al.
patent: 6090826 (2000-07-01), Chandraratna
patent: 6114348 (2000-09-01), Weber et al.
patent: 01-10172 (2002-03-01), None
patent: 02-00001 (2002-07-01), None
patent: 98-03355 (1997-08-01), None
patent: 01-10410 (2001-10-01), None
Nara, N. Leuk Lymphoma. Jun. 1993;10(3):201-7.
Fanjul et al., Cancer Research 56, 1571-1577 (1996).
Toma et al., International Journal of Oncology 10: 597-607 (1997).
Kurbacher et al., Cancer Letters 103 (1996) 183-189.
Aapro et al., Cancer Chemother. Pharmacol. 10: 161-166 (1983).
Marth et al., J. Natl. Cancer Inst., 77: 1197-1202 (1986).
DiSepio et al.,Retinoic Acid Receptor-Nuclear Factor-Interleukin 6 Antagonism, XP-001127433, The Journal of Biologial Chemistry, vol. No. 41, Issue of Oct. 10, pp 25555-25559 (1997).
Shi-Yong Sun and Reuben Lotan,Retinoids as chemopreventive and therapeutic agents, XP008010833, Drugs of the Future 1998, 23(6): 621-634 (1998).
Beard Richard L.
Chandraratna Roshantha A.
Nehme Alissar
Allergan Inc.
Baran Robert J.
Johnson Brent A.
Landsman Robert
Voet Martin A.
LandOfFree
TREATMENT OF TUMORS WITH ACETYLENES DISUBSTITUTED WITH A... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TREATMENT OF TUMORS WITH ACETYLENES DISUBSTITUTED WITH A..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TREATMENT OF TUMORS WITH ACETYLENES DISUBSTITUTED WITH A... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3520244